Taysha Gene Therapies, Inc. (TSHA) has 1 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 1 sales totalling $1.2M. Most recent filing: July 10, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| July 10, 2026 | Nagendran Sukumar President and Head of R&D | −$1,248,000 | 200,000 | −18% | Yes | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free